EMSA

Emsa İlaç is a Turkish pharmaceutical company founded in 1970 that specializes in the development and manufacturing of generic and branded medications. In 2015, the company was acquired by Abdi İbrahim, the largest pharmaceutical company in Turkey, which integrated Emsa's operations into its extensive production network. Emsa İlaç maintains a diverse product portfolio focusing on therapeutic areas such as respiratory health, cardiovascular diseases, and central nervous system disorders. The company operates a GMP-certified manufacturing facility in Istanbul, ensuring high-quality standards for its domestic and international markets. Through its partnership with Abdi İbrahim, Emsa İlaç continues to provide affordable healthcare solutions and expand its global export footprint.